Role of the Pyk2-MAP kinase-cPLA 2 signaling pathway in shear-dependent platelet aggregation

Annals of Biomedical Engineering

Volumn 32, Issue 9, 2004, Pages 1193-1201

  Sun, Lei ^a   Feng, Shuju ^a   Reséndiz, Julio C ^b   Xin, L U ^a   Durante, William ^a   Kroll, Michael H ^a,c  

^a RICE UNIVERSITY   (United States)

^b WIHURI RESEARCH INSTITUTE   (Finland)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Aspirin; Shear stress; Tyrosine kinases

Indexed keywords

CYTOSKELETAL TETHERING; GLYCOPROTEINS; PLATELET AGGREGATION; SIGNAL PATHWAYS;

BINDING ENERGY; FLUORESCENCE; METABOLISM; PATHOLOGY; PLASMAS; SHEAR STRESS; SODIUM COMPOUNDS;

DRUG PRODUCTS;

ACETYLSALICYLIC ACID; ACYLTRANSFERASE; ARACHIDONIC ACID; FOCAL ADHESION KINASE 2; HTATIP2 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ARTICLE; CELL CULTURE; DRUG EFFECT; HUMAN; MECHANICAL STRESS; MECHANOTRANSDUCTION; METABOLISM; PHYSIOLOGY; SHEAR STRENGTH; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ACETYLTRANSFERASES; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 2; HUMANS; MECHANOTRANSDUCTION, CELLULAR; PLATELET AGGREGATION; PROTEIN-TYROSINE KINASES; SHEAR STRENGTH; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TRANSCRIPTION FACTORS;

EID: 5444264954     PISSN: 00906964     EISSN: None     Source Type: Journal    
DOI: 10.1114/B:ABME.0000039353.97347.28     Document Type: Article

References (34)

1. Asazuma, N., Y. Ozaki, K. Satoh, Y. Yatomi, M. Handa, Y. Fujimura, S. Miura, and S. Kume. Glycoprotein Ib-von Wille-brand factor interactions activate tyrosine kinases in human platelets. Blood 90:4789-4798, 1997.
2. Börsch-Haubold, A. G., F. Ghomashchi, S. Pasquet, M. Goedert, P. Cohen, M. H. Gelb, and S. P. Watson. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways. Eur. J. Biochem. 265:195-203, 1999.
3. Canobbio, I., P. Lova, E. Hirsch, F. Siniaglia, C. Balduini, and M. Torti. Proline-rich tyrosine kinase 2 and focal adhesion kinase are involved in different phases of platelet activation by VWF. Thromb. Haemost. 87:509-517, 2002.
4. Coller, B. S. Anti-GPIIb/IIIa drugs : Current strategies and future directions. Thromb, Haemost. 86:427-443, 2001.
5. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105, 2000.
6. Feng, S., J. C. Reséndiz, N. Christodoulides, X. Lu, D. Arboleda, M. C. Berndt, and M. H. Kroll. Pathological shear stress stimulates the tyrosine phosphorylation of α-actinin associated with the glycoprotein Ib-IX complex. Biochemistry 41:1100-1108, 2002.
7. Feng, S., J. C Reséndiz, X. Lu, and M. H. Kroll. Filamin A binding to the cytoplasmic tail of glycoprotein Ibα regulates von Willebrand factor-induced platelet activation. Blood 102:2122-2129, 2003.
8. Huang, P. Y., and J. D. Hellums. Aggregation and disaggregation kinetics of human blood platelets: Part II. Shear-induced platelet aggregation. Biophys. J. 65:344-353, 1993.
9. Jackson, S. P., and S. M. Schoenwaelder. Anti-platelet therapy - in search of the magic bullet. Nat. Rev. Drug Discov. 2:775-789, 2003.
10. Kato, K., T. Kanaji, S. Russell, T. J. Kunicki, K. Furihata, S. Kanaji, S. P. Marchese, A. Reininger, Z. M. Ruggeri, and J. Ware. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102:1701-1707, 2003.
11. Kroll, M. H., T. S. Harris, J. L Moake, R. I. Handin, and A. I. Schafer, von Willebrand factor binding to platelet glycoprotein Ib initiates signals for platelet activation. J. Clin. Invest. 88:1568-1573, 1991.
12. Kroll, M. H., J. D. Hellums, L. V. McIntire, A. I. Schafer, and J. L. Moake. Platelets and shear stress. Blood 88:1525-1541, 1996.
13. Li, Z., X. Xi, and X. Du. A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin αIIbβ3. J. Biol. Chem. 276:42226-42232, 2002.
14. Lin, L.-L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278, 1993.
15. Maclouf, J., H. Kindahl, E. Granstrom, and B. Samuelsson. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin. Eur. J. Biochem. 109:561-566, 1980.
16. Mazzucato, M., L. De Marco, P. Pradella, A. Masotti, and F. I. Pareti. Porcine von Willebrand factor binding to human platelet GpIb induces transmembranous calcium influx. Thromb. Haemost. 75:655-660, 1996.
17. Mazzucato, M., P. Pradella, M. R. Cozzi, L. De Marco, and Z. M. Ruggeri. Sequential cytoplasmic signals in a 2-stage platelet activation process induced by the glycoprotein Ibα mechanore-ceptor. Blood 100:2793-2800, 2002.
18. McNichol, A., and E. C. G. Jackson. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem. Pharm. 65:1243-1250, 2003.
19. Moake, J. L., N. A. Turner, N. A. Stathopoulos, L. H. Nolasco, and J. D. Hellums. Shear-induced platelet aggregation can be mediated by VWF released from platelets, as well as exogenous large or unusually large VWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 71:1366-1374, 1988.
20. Murasawa, S., Y. Mor, Y. Nozawa, H. Masaki, K. Maruyama, Y. Tsutsumi, Y. Moriguchi, Y. Shibasaki, Y. Tanaka, T. Iwasaka, M. Inada, and H. Matsubara. Role of calcium-sensitive tyrosine kinase Pyk2/C AKβ/RAFTK in angiotensin II-induced Ras/ERK signaling. Hypertension 32:668-675, 1998
21. Navdaev, A., and K. J. Clemetson. Glycoprotein Ib cross-linking/ligation on echicetin coated surfaces or echicetin-IgMk in stirred suspension activates platelets cytoskeleton modulated calcium release. J. Biol. Chem. 277:45928-45934, 2002.
22. Ohmori, T., Y. Yatomi, N. Asazuma, K. Satoh, and Y. Ozaki. Involvement of proline-rich tyrosine kinase 2 in platelet activation: Tyrosine phosphorylation is mostly dependent on α11b,β3 integrin and protein kinase C, translocation to the cytoskeleton and association with She through Grb2. Biochem, J. 347:561-569, 2000.
23. Ozaki, Y., K. Satoh, Y. Yatomi, S. Miura, Y. Fujimura, and S. Kume. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Wille-brand factor. Biochim. Biophys. Acta 1243:482-488, 1995.
24. Pandey, P., S. Avraham, S. Kumar, A. Nakazawa, A. Place, L. Ghanem, A. Rana, V. Kumar, P. K. Majumder, H. Avraham, R. J. Davis, and S. Kharbanda. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J. Biol. Chem. 274:10140-10144, 1999.
25. Raja, S., S. Avraham, and H. Avraham. Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa independent mechanism. J. Biol. Chem. 212:10941-10947, 1997.
26. Rajagopalan, S., L. V. McIntire, E. R. Hall, and K. K. Wu. The stimulation of arachidonic acid metabolism in human platelets by hydrodynamic stresses. Biochim. Biophys. Acta 958:108-115,1988.
27. 12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation. Mol. Pharmacol. 63:639-645, 2003.
28. Ruggeri, Z. M. Platelets in atherothrombosis. Nat. Med. 8:1227-1234, 2002.
29. Sadler, J. E. Contact - how platelets touch von Willebrand factor. Science 297:1128-1129, 2002.
30. Savage, B., F. Almus-Jacobs, and Z. M. Ruggeri. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94:657-666, 1998.
31. Shattil, S. J. Signalling through platelet integrin αIIbβ3: Inside-out, outside-in, and sideways. Thromb. Haemost. 82:318-325, 1999.
32. Song, S., J. Freedman, M. Mody, and A. H. Lazarus. p38 MAPK is activated but not necessary in porcine von Willebrand factor-dependent platelet activation. Br. J. Haematol. 107:532-538, 1999.
33. Wang, Z., T. M. Leisner, and L. V. Parise. Platelet α2β 1 integrin activation: Contribution of ligand intemalization and the α2-cytoplasmic domain. Blood 102:1307-1315, 2003.
34. Williams, S. B., L. P. McKeown, and H. R. Gralnick. Asialo von Willebrand factor binding to and aggregation of platelets; Effects of inhibitors of platelet metabolism and function. J. Lab. Clin. Med. 109:560-565, 1987.